One of the demands raised during the protests was access to 'Elevidys', a one-time gene therapy treatment that has the ...

When her son reached three last year, a new name loomed over their lives — Duchenne Muscular Dystrophy (DMD), a ...

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best known for causing ...

Amid readouts from the Muscular Dystrophy Association’s annual meeting, the Clinical Trials Arena evaluates five DMD trials ...

An 8-year-old northern Minnesota boy is one of the first in the country to receive a specific type of gene therapy treatment.

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...

The Cambridge-based biotech's experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, ...

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best ... these changes is crucial to developing treatments that address the full scope of ...

Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...